Charmaine D. Rochester, PharmD, CDE, BCPS Associate Professor of Pharmacy University of Maryland, School of Pharmacy Department of Pharmacy Practice and Science Baltimore, MD
Pharmacists: 1.0 Contact Hour (0.10 CEU)
Link - Online
The live version of this activity took place on November 8, 2012 in National Harbor, MD. If you attended and received credit for the live event you may NOT receive credit for this archived event.
The prevalence of type 2 diabetes mellitus (T2DM) has reached an epidemic level and continues to rise. The American Diabetes Association (ADA) estimates that 25.8 million people, approximately 8.3% of the U.S. population, have diabetes. In the older adult population the prevalence of diabetes is even higher. Approximately 26.9% of all people over age 65 in the United States (10.9 million people total) have diabetes. Despite numerous treatment approaches and pharmacologic agents, the management of older adults with T2DM remains a major clinical challenge, and a large proportion of patients do not achieve optimal glycemic control. While recognizing that many factors contribute to suboptimal glycemic control in patients with T2DM, this workshop will focus on two major barriers that hinder older adults from achieving their glycemic goals: hypoglycemia and patient non-adherence to treatment regimens. The goal of this continuing education activity is to expand the ability of senior care pharmacists to recommend tailored T2DM treatment plans with particular attention to overcoming the barriers of hypoglycemia and patient non-adherence, ultimately improving glycemic control for older adults with T2DM.
This online activity is the recorded version of a mini workshop conducted at the ASCP 2012 Annual Meeting. The online version utilized information discussed on the 2 cases from the live workshop groups.
. Target Audience
Senior care pharmacists and others interested in the care of older patients with diabetes.
Upon completion of this educational activity, the participant should be able to:
Outline strategies to overcome common barriers to suboptimal glycemic control in older adults with type 2 diabetes.
Identify patients who would benefit from diabetes therapy intensification.
Recommend treatment adjustments for older adults with type 2 diabetes experiencing hypoglycemia.
Adjust treatment regimens for patients with type 2 diabetes to minimize adverse events.
It is the policy of the ASCP to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Dr. Rochester discloses that she receives research support from sanofi aventis.
Dr. Sara Thier has no relevant financial conflicts to disclose.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Credit Statements
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-12-134-H01-P, has been assigned 1.00 Contact Hour (0.10 CEU).
Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 75% or better, and a statement may be printed immediately after passing the post-test.
There is no fee to participate in this educational activity.
Commercial Support Statements
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
This activity is hosted by ASCP Education.
To access this activity you will have need to log in with your ASCP logon credentials.
If you are not a member of ASCP, please go to education.ascp.com to register as a guest user.